This all happened in a chain reaction after the Brazilian government suspended its deal with Bharat Biotech to procure 20 million doses of Covaxin. Here is what went wrong in Bharat Biotech's Covaxin deal in BrazilIn November 2020, Bharat Biotech entered into an agreement with Precisa Medicamentos and Envixia Pharmaceuticals LL.C. The Bolsonaro government faced allegations of corruption regarding its agreement with Bharat Biotech which is still under investigation. Whistleblowers from Brazil's health department said there was pressure from higher authorities regarding the Bharat Biotech deal. Now that the deal stands cancelled, Bharat Biotech said it will work with Anvisa diligently to complete the regulatory approval process.

Source: Hindustan Times July 24, 2021 09:56 UTC